COMMUNIQUÉS West-GlobeNewswire

OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier
20/08/2025
NANTES, France - 20 août 2025, 18 h 00 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , annonce aujourd’hui la nomination de Thomas Gidoin au poste de Directeur Financier. Thomas rejoint le Comité Exécutif [...]
BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety
20/08/2025
Unique nootropic formula blends botanical extracts, amino acids and neuro-support nutrients to support balance, energy and resilience in athletes LAS VEGAS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc [...]
2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement
20/08/2025
Novonesis today announces its ‘GROW’ strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and significant re-investments to secure long-term growth. By 2030 [...]
BioAegis Therapeutics Awarded Second FDA Fast Track Designation for Recombinant Human Gelsolin to Treat Inflammasome-Driven Decompression Sickness (DCS)
20/08/2025
Fast Track status accelerates regulatory pathway for BioAegis’ recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases. Second Fast Track designation in recent months highlights [...]
EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension
20/08/2025
TARRYTOWN, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended the target action dates to the fourth [...]
Glaucoma Research Foundation Launches Treatment Accelerator with Transformative $5 Million Gift
20/08/2025
Largest-ever gift to Glaucoma Research Foundation moves vision-restoration discoveries from lab to clinic faster than ever before SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation is proud to [...]
InfoAging Launches Florida’s First Comprehensive “Care Team Finder” to Tackle Senior Health Crisis
20/08/2025
Miami, Florida, Aug. 20, 2025 (GLOBE NEWSWIRE) -- InfoAging , a specialized health directory for senior-focused care, today announced the launch of InfoAging.org , Florida’s first comprehensive “Care Team Finder” [...]
Keros Announces U.S. FDA Orphan Drug Designation Granted to KER-065 for the Treatment of Duchenne Muscular Dystrophy
20/08/2025
LEXINGTON, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a [...]
Novo Nordisk to present Wegovy® and Ozempic® data showing life-saving cardiovascular benefits for people living with obesity and type 2 diabetes at the European Society of Cardiology Congress 2025
20/08/2025
Data to highlight the impact of Wegovy ® (semaglutide 2.4 mg) on atrial fibrillation – a common heart rhythm condition – in people living with obesity (SELECT study) Additional Rybelsus ® and Ozempic ® data demonstrate [...]
Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences
20/08/2025
STAFFORD, Texas, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering
20/08/2025
SAN DIEGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with [...]
Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference
20/08/2025
MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging- [...]
Regulatory Approval Granted for Commencement of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation
20/08/2025
Approval Facilitates Immediate Offshored and Outsourced Manufacturing Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to [...]
Eleos Launches AI Scanner to Navigate Medicaid Eligibility Risk in Real Time
20/08/2025
The new OBBBA AI scanner uses Eleos’ ambient AI technology to alert providers of patient eligibility changes, preserving revenue and ensuring care continuity amid sweeping Medicaid policy changes BOSTON, Aug. 20, 2025 ( [...]
Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control
20/08/2025
--Advances European commercialization strategy following CE mark approval-- ATLANTA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical [...]
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share
20/08/2025
WALTHAM, Mass. and DUBLIN and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“ Mural ”), and XOMA Royalty Corporation (Nasdaq: XOMA), a [...]
Option Care Health Announces Chief Financial Officer Transition
20/08/2025
Mike Shapiro to Step Down After 10 Years With the Company; Meenal Sethna Named EVP and CFO Effective October 1, 2025 BANNOCKBURN, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “ [...]
Earth Science Tech, Inc. Boosts Share Repurchase Program to $10 Million and Extends Authorization Through 2027
20/08/2025
Miami, Fla., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential businesses, today announced its [...]
Easy Environmental Solutions Launches Terreplenish Trials in Tanzania, Opening Door to Multi-Unit Deployment
20/08/2025
MANKATO, Minn., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Digital Utilities Ventures, Inc. (OTC: DUTV), operating as Easy Environmental Solutions Inc., today announced a strategic collaboration with the Tanzania Fertilizer [...]

Pages